Research Desk

Jun 14, 2019

 

 

Watch Dr. Itzhak Fried present "Laser Ablation for Epilepsy" at UCLA Neurosurgery Update 2019. UCLA Neurosurgery at the David Geffen School of Medicine at UCLA presented its second annual comprehensive update on emerging diagnostic and treatment modalities for diseases of the brain and spine, drawing upon the department's world-class expertise in each sub-specialty.

Jun 14, 2019

Watch Dr. Harvey Fishman, MD, Ph.D. discuss the role of intense pulsed light therapy to treat OSD. Eradicating Demodex helps keep the ocular microbiome healthy. 

Jun 14, 2019

This webinar presents the infection risks associated with different vascular access types. Discussion includes strategies and recommendations for successful catheter reduction to prevent bloodstream infections. It includes a presentation on “Incident Vascular Access and Risk of Bloodstream Infection Among New ESRD Patients Receiving Hemodialysis” followed by a conversation about achieving optimal vascular access for patient safety.

Jun 14, 2019

 

Watch Dr. Amy J. Bregar, MD, a gynecologic oncologist with the Center for Gynecologic Oncology at Mass General, discuss the current recommendations for cancer screening and prevention for women as they age.

Jun 14, 2019

Watch UCLA gastroenterologist Dr. Lisa Lin, MD discuss the symptoms of acid reflux, how to test for it and the available treatment options.

Jun 13, 2019

Nitin Walyat from LSU Health Shreveport presented a talk on Preterm Infants and their Body composition as little is known about the changes in the body composition in preterm infants as they approach corrected age. Also pre natal growth lag is seen to be associated with poor neurodevelopmental outcomes. 

Jun 13, 2019

Martha Grogan presented a talk on Cardiac Amyloidosis with an aim to discuss updates on diagnosis, treatment and management of cardiovascular disease., integrate data and available technique in order to reach appropriate treatment decisions. and describing research models, methods and statistical tools.

Jun 13, 2019

R. Jonathan Henderson, MD, argues that the goal of ADT should be to achieve and maintain the lowest levels of T possible in prostate cancer patients. The FDA-recommended target low of 50 ng/dL originates from constraints of outdated technology, and multiple studies indicate that there is a benefit to patients when T-levels fall below 20 ng/dL.

Jun 13, 2019

Scott H. Sicherer presented a talk on Food Allergy with respect to evaluate the clinical manifestation in food allergies, utlisizing diagnostic tools in the mangement of allergy in diagnostic tools, describing current management, treatment and prevention of food allergies. 

Jun 13, 2019

Petra J. Lewis from Yale Radiology and Biomedical Imaging presented a talk on Learning and Memory with an objective to outline the basic process involved in the memorization and recall and explaining why spaced interval testing results in better learning than repeated review.